Letter to the Editor
Bone Marrow Transplantation (2008) 41, 409–410; doi:10.1038/sj.bmt.1705927; published online 19 November 2007
Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients
C H Hui1, H Sia1, H Mangos1, N Horvath1, H Lee1, I Lewis1, T Hughes1, L B To1 and P Bardy1
1Institute of Medical and Veterinary Science, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Correspondence: CH Hui, E-mail: chi-hung.hui@imvs.sa.gov.au
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Innovative approaches to treat steroid-resistant or steroid refractory GVHD
Bone Marrow Transplantation Review
RESEARCH
Bone Marrow Transplantation Original Article
Daclizumab for children with corticosteroid refractory graft-versus-host disease
Bone Marrow Transplantation Original Article
Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
Bone Marrow Transplantation Original Article
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
Bone Marrow Transplantation Original Article
